scPharmaceuticals Profit Margin

scPharmaceuticals (SCPH) currently reports a profit margin of -183.55% as of June 2025. That compares with -252.18% in the prior-year period — up 27.2% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore scPharmaceuticals's profit margin history and peer comparisons.

scPharmaceuticals's profit margin increased from -252.18% to -183.55% — a 27.2% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

scPharmaceuticals's profit margin of -183.55% is lower than the Healthcare sector average of 10.58%. That is roughly 1834.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but scPharmaceuticals's current -183.55% should be judged against Healthcare norms (sector average: 10.58%) and against SCPH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -183.55%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for scPharmaceuticals, and consider following SCPH for alerts when major investors trade the stock.